Skip to main content
Top

Cancer Causes & Control

An International Journal of Studies of Cancer in Human Populations

1997 - 2024
Volumes
298
Issues
Chevron right icon
Issue 10/2024
Latest issue

Cancer Causes & Control OnlineFirst articles

About this journal

Cancer Causes & Control is an international refereed journal that both reports and stimulates new avenues of investigation into the causes, control, and subsequent prevention of cancer. Its multidisciplinary and multinational approach draws together information published in a diverse range of journals.

Coverage extends to variation in cancer distribution within and between populations; factors associated with cancer risk; preventive and therapeutic interventions on a population scale; economic, demographic, and health-policy implications of cancer; and related methodological issues.

Cancer Causes & Control publishes original articles, reviews, short communications, commentaries, opinions, and letters to the editor which have direct relevance to researchers and practitioners working in epidemiology, medical statistics, cancer biology, health education, medical economics and related fields. The journal also provides significant information for government agencies concerned with cancer research, control and policy.

Metadata
Title
Cancer Causes & Control
Coverage
Volume 8/1997 - Volume 35/2024
Publisher
Springer International Publishing
Electronic ISSN
1573-7225
Print ISSN
0957-5243
Journal ID
10552
DOI
https://doi.org/10.1007/10552.1573-7225
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

  • Webinar | 01-10-2024 | 12:30 (CEST)

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Get a reminder for the on-demand version